Pharmacotherapy of pervasive developmental disorders

R. Tuchman, J. Gilman

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pervasive developmental disorders (PDDs) are severe developmental disabilities defined by behavioral criteria. Our present understanding of the neurobiological basis of this disorder is limited. Clinicians treating children with PDDs must be aware of the varying severity of manifestations and the lifelong nature of this disorder. The current clinical role of pharmacotherapy in the management of PDDs is to ameliorate behavioral symptoms that are interfering with the individual's ability to participate in educational, social and family systems. In this paper we review some of the medications which have shown positive effects in the treatment of children with PDDs.

Original languageEnglish
Pages (from-to)211-218
Number of pages8
JournalInternational Pediatrics
Volume8
Issue number2
StatePublished - Jan 1 1993

Fingerprint

Drug Therapy
Behavioral Symptoms
Developmental Disabilities
Aptitude
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Tuchman, R., & Gilman, J. (1993). Pharmacotherapy of pervasive developmental disorders. International Pediatrics, 8(2), 211-218.

Pharmacotherapy of pervasive developmental disorders. / Tuchman, R.; Gilman, J.

In: International Pediatrics, Vol. 8, No. 2, 01.01.1993, p. 211-218.

Research output: Contribution to journalArticle

Tuchman, R & Gilman, J 1993, 'Pharmacotherapy of pervasive developmental disorders', International Pediatrics, vol. 8, no. 2, pp. 211-218.
Tuchman, R. ; Gilman, J. / Pharmacotherapy of pervasive developmental disorders. In: International Pediatrics. 1993 ; Vol. 8, No. 2. pp. 211-218.
@article{bb71194657054108b3711da6b6952a99,
title = "Pharmacotherapy of pervasive developmental disorders",
abstract = "Pervasive developmental disorders (PDDs) are severe developmental disabilities defined by behavioral criteria. Our present understanding of the neurobiological basis of this disorder is limited. Clinicians treating children with PDDs must be aware of the varying severity of manifestations and the lifelong nature of this disorder. The current clinical role of pharmacotherapy in the management of PDDs is to ameliorate behavioral symptoms that are interfering with the individual's ability to participate in educational, social and family systems. In this paper we review some of the medications which have shown positive effects in the treatment of children with PDDs.",
author = "R. Tuchman and J. Gilman",
year = "1993",
month = "1",
day = "1",
language = "English",
volume = "8",
pages = "211--218",
journal = "International Pediatrics",
issn = "0885-6265",
publisher = "Miami Children's Hospital Medical Journal Inc.",
number = "2",

}

TY - JOUR

T1 - Pharmacotherapy of pervasive developmental disorders

AU - Tuchman, R.

AU - Gilman, J.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Pervasive developmental disorders (PDDs) are severe developmental disabilities defined by behavioral criteria. Our present understanding of the neurobiological basis of this disorder is limited. Clinicians treating children with PDDs must be aware of the varying severity of manifestations and the lifelong nature of this disorder. The current clinical role of pharmacotherapy in the management of PDDs is to ameliorate behavioral symptoms that are interfering with the individual's ability to participate in educational, social and family systems. In this paper we review some of the medications which have shown positive effects in the treatment of children with PDDs.

AB - Pervasive developmental disorders (PDDs) are severe developmental disabilities defined by behavioral criteria. Our present understanding of the neurobiological basis of this disorder is limited. Clinicians treating children with PDDs must be aware of the varying severity of manifestations and the lifelong nature of this disorder. The current clinical role of pharmacotherapy in the management of PDDs is to ameliorate behavioral symptoms that are interfering with the individual's ability to participate in educational, social and family systems. In this paper we review some of the medications which have shown positive effects in the treatment of children with PDDs.

UR - http://www.scopus.com/inward/record.url?scp=0027203095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027203095&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 211

EP - 218

JO - International Pediatrics

JF - International Pediatrics

SN - 0885-6265

IS - 2

ER -